Featured Research

from universities, journals, and other organizations

Bone Marrow Transplantation Success Marred By Side Effects Of Kidney Failure

Date:
January 5, 2001
Source:
Medical College Of Wisconsin
Summary:
While there has been a dramatic increase in the use of bone marrow transplantation (BMT) to treat patients with cancer it has come at a high price. One of the major side effects of curing cancer patients is the high rate of acute and chronic renal failure.

While there has been a dramatic increase in the use of bone marrow transplantation (BMT) to treat patients with cancer it has come at a high price. One of the major side effects of curing cancer patients is the high rate of acute and chronic renal failure, according to an editorial in the Jan. 4, 2000, issue of Lancet by Eric Cohen, M.D., associate professor of medicine at the Medical College of Wisconsin in Milwaukee.

Currently, five to 15 per cent of all patients undergoing bone marrow transplants develop acute kidney failure. Of the long-term BMT survivors, five to 20 percent develop chronic kidney failure. "This is a major problem," says Dr. Cohen, "and needs to be addressed by the research community."

At the Medical College, Dr. Cohen and his team are studying ways to prevent kidney damage. In animal studies they found that ace inhibitors, used to treat high blood pressure and reduce kidney injuries, were effective in preventing kidney damage. A randomized, double-blind study is being done in humans with the ace inhibitor captopril to prevent problems with chronic kidney failure. For more information or to participate in the study call Victoria Johnson at 414-805-4632.

In the last 20 years, the number of BMTs done world wide to cure cancer, jumped from a few hundred to 40,000 autologous or self-transplants, and 15,000 allogeneic or donor transplants.

The complications of kidney failure are directly related to the process and course of BMT including pre-transplantation high-dose chemotherapy and total body radiation therapy to kill off the cancer cells. The resulting weakened immune system can lead to infections and other complications resulting in kidney failure. Additionally, anti-rejection drugs used to prevent the graft vs. host disease in donor transplants can be toxic to the kidney.

Dr. Cohen points out that chronic kidney failure was recognized over ten years ago as being related to total body irradiation. He believes that genetic factors may explain why there is such a wide variability in radiation-induced tissue injury. A better understanding of this response and the ability to identify people most at risk for normal tissue-radiation injury would lead to better use of radiation therapy before BMT and other uses.


Story Source:

The above story is based on materials provided by Medical College Of Wisconsin. Note: Materials may be edited for content and length.


Cite This Page:

Medical College Of Wisconsin. "Bone Marrow Transplantation Success Marred By Side Effects Of Kidney Failure." ScienceDaily. ScienceDaily, 5 January 2001. <www.sciencedaily.com/releases/2001/01/010105075527.htm>.
Medical College Of Wisconsin. (2001, January 5). Bone Marrow Transplantation Success Marred By Side Effects Of Kidney Failure. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2001/01/010105075527.htm
Medical College Of Wisconsin. "Bone Marrow Transplantation Success Marred By Side Effects Of Kidney Failure." ScienceDaily. www.sciencedaily.com/releases/2001/01/010105075527.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins